Deinfibulation can prevent or treat gynecological and obstetric complications in women living with type III female genital mutilation (FGM), and subsequently improve childbirth outcomes. Recently published WHO guidelines recommend use of deinfibulation in both circumstances. However, to really impact practice, evidencebased guidance needs to be matched with evidence-based implementation strategies. This qualitative evidence synthesis provides information on the factors that facilitate or act as barriers to use of deinfibulation, and the context and conditions that are necessary for implementing the procedure, including healthcare providers' knowledge and experience, the service delivery environment, as well as broader health system contexts. This information is of great value for policy makers and others considering this as an option for better clinical care of women living with
| SUMMARY OF THE EVIDENCESix studies were included in the qualitative synthesis (more detailed methods in Stein et al. 4 ). All identified studies were conducted in the following high-income countries: France (n=1), 5 Norway (n=2), 6,7 Sweden (n=2), 8,9 and the UK (n=1), 3 and included immigrant women and healthcare providers as participants. Two studies specifically explored women's experience of deinfibulation, three explored healthcare providers' experiences of caring for women with FGM during pregnancy and childbirth, and in one the focus was on women's motivations for clitoral repair.